These findings indicate a high mutation frequency of CIITA and LATS2 in ccRCC; CIITA, IL10RA, and OAS3 in pRCC; and CSF2RB and CDKN1A in chRCC. This evidence concerns the gene LATS2 and nonpapillary renal cell carcinoma.